Although the difference was not statistically significant, the incidence of AAAs following 3 weeks of AngII infusion was 67% (3 Wks AngII), as compared to a 36% AAA incidence in mice that received an additional 5 weeks of celecoxib treatment (Figure 2A). Here, AGT is linked to triple-A syndrome.